HPK1-IN-13
HPK1-IN-13 is potent inhibitor of HPK1. HPK1 is a serine/threonine protein kinase cloned from hematopoietic progenitor cells and belongs to the MAP4K family of mammalian Ste-20-related protein kinases. HPK1-IN-13 has the potential for the research of HPK1 related diseases (extracted from patent WO2021213317A1, compound 64) [1].
Product Specifications
CAS Number
2734168-30-8
UNSPSC
12352005
Target
MAP4K
Type
Reference compound
Related Pathways
MAPK/ERK Pathway
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/hpk1-in-13.html
Solubility
10 mM in DMSO
Smiles
FC1=C(C2=CC3=C(NN=C3C4=CC(OCC5N6CCN(C5)C)=C6C=C4)C=N2)C(OC)=CC=C1
Molecular Formula
C25H24FN5O2
Molecular Weight
445.49
References & Citations
[1]Xie, Yuli, et al. Hpk1 inhibitor and preparation method and use thereof. Patent WO2021213317A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![PE Conjugated Human CD8 alpha Recombinant Mouse Monoclonal Antibody [PSH04-94]](https://cdn.genprice.uk/products/992/68dd1c8c061270361ea81a22/imageurl/ha600123f.webp)
PE Conjugated Human CD8 alpha Recombinant Mouse Monoclonal Antibody [PSH04-94]
PCNA (Proliferating Cell Nuclear Antigen) (G1- & S-phase Marker) (PC5), CF568 conjugate, 0.1mg/mL
